GLOBEALERT
HEALTH● LOWSep 2 · Sep 2, 2026, 12:24 PM

United Therapeutics bid to expand nebulized Tyvaso label gets FDA review

Seeking Alpha Tech · north america

United Therapeutics' request to expand the label for nebulized Tyvaso is under review by the FDA. This indicates a potential broadening of the drug's approved uses.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

More in Health